National conference examines HIV/AIDS in women. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


National conference examines HIV/AIDS in women. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

GMHC Treat Issues. 1995 Mar;9(3):1-3. Unique Identifier : AIDSLINE AIDS/95700383
Hoyt MJ


Abstract: The Second Conference on HIV Infection in Women, held in Washington, D.C. on February 22 to 24, offered data addressing the manifestation of HIV infection and AIDS progression in women, including wasting syndrome, vertical transmission, pregnancy and CD4 count, genital tract infections, cervical disease, and HPV (Human Papillomavirus). Clinical data on HIV progression in women shows that women were one-third more likely than men to experience death as the first clinical event after study enrollment, but among those who survived, there was no difference in progression between men and women. It was reported that male and female hormones could create major gender differences in wasting syndrome. Two studies addressing different issues related to transmission of HIV infection from pregnant women to their infants indicate 1) plasma HIV-1 RNA level at delivery correlated strongly with vertical transmission, 2) AZT did not appear to have an effect on vertical transmission, and 3) viral RNA titers remained stable throughout pregnancy in women not taking antivirals or who remained on one antiviral treatment throughout. Other data presented show a relationship between HIV-positive pregnant women and vitamin A deficiencies; their newborns had a higher infant mortality rate. Pregnancy was found to not affect CD4 or CD8 counts. Candida vaginitis was significantly associated with HIV, but not bacterial vaginosis, trichomoniasis, syphilis, chlamydia, or gonorrhea. Studies have shown that cervical intraepithelial neoplasia (CIN) is more common in HIV-infected women. The conference presented studies that explored whether Pap or colposcopy-confirmed CIN was the best screening test.
Keywords: *Acquired Immunodeficiency Syndrome Cervical Intraepithelial Neoplasia/COMPLICATIONS CD4 Lymphocyte Count Disease Progression Disease Transmission, Vertical Female Genital Diseases, Female/COMPLICATIONS Human *HIV Infections Infant, Newborn Pregnancy Pregnancy Complications, Infectious Sex Factors Weight Loss NEWSLETTER ARTICLE

KWDacquiredimmunodeficiencysyndromecervicalintraepithelialneoplasia/complicationscd4lymphocytecountdiseaseprogressiondiseasetransmission,verticalfemalegenitaldiseases,female/complicationshumanKWDhivinfectionsinfant,newbornpregnancypregnancycomplications,infectioussexfactorsweightlossnewsletterarticle
951130
M95B0883


Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .